Literature DB >> 21509468

First-line metronomic chemotherapy in a metastatic model of spontaneous canine tumours: a pilot study.

Veronica Marchetti1, Mario Giorgi, Anna Fioravanti, Riccardo Finotello, Simonetta Citi, Bastianina Canu, Paola Orlandi, Teresa Di Desidero, Romano Danesi, Guido Bocci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21509468     DOI： 10.1007/s10637-011-9672-y

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  35 in total

1.  Veterinary Co-operative Oncology Group - Common Terminology Criteria for Adverse Events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0.

Authors: 
Journal:  Vet Comp Oncol       Date:  2004-12       Impact factor: 2.613

2.  Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab.

Authors:  Angelica Calleri; Anna Bono; Vincenzo Bagnardi; Jessica Quarna; Patrizia Mancuso; Cristina Rabascio; Silvia Dellapasqua; Elisabetta Campagnoli; Yuval Shaked; Aron Goldhirsch; Marco Colleoni; Francesco Bertolini
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

3.  High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and refractory aggressive histology non-Hodgkin's lymphoma.

Authors:  Rena Buckstein; Robert S Kerbel; Yuval Shaked; Rakesh Nayar; Cindy Foden; Ruth Turner; Christine R Lee; Diane Taylor; Liying Zhang; Shan Man; Sylvain Baruchel; Diana Stempak; Francesco Bertolini; Michael Crump
Journal:  Clin Cancer Res       Date:  2006-09-01       Impact factor: 12.531

Review 4.  Translation of new cancer treatments from pet dogs to humans.

Authors:  Melissa Paoloni; Chand Khanna
Journal:  Nat Rev Cancer       Date:  2008-02       Impact factor: 60.716

5.  Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles.

Authors:  Robert Klopfleisch; Dido Lenze; Michael Hummel; Achim D Gruber
Journal:  BMC Cancer       Date:  2010-11-09       Impact factor: 4.430

6.  Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens.

Authors:  William Cruz-Munoz; Shan Man; Robert S Kerbel
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

Review 7.  Pet models in cancer research: general principles.

Authors:  A Porrello; P Cardelli; E P Spugnini
Journal:  J Exp Clin Cancer Res       Date:  2004-06

8.  Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma.

Authors:  L Michael Glode; Albaha Barqawi; Frances Crighton; E David Crawford; Robert Kerbel
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860

9.  To widen the setting of cancer patients who could benefit from metronomic capecitabine.

Authors:  Margherita Nannini; Elisabetta Nobili; Roberto Di Cicilia; Giovanni Brandi; Alessandra Maleddu; Maria A Pantaleo; Guido Biasco
Journal:  Cancer Chemother Pharmacol       Date:  2009-01-17       Impact factor: 3.333

10.  Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs.

Authors:  Robert S Kerbel
Journal:  Cancer Res Treat       Date:  2007-12-31       Impact factor: 4.679
View more
  5 in total

1.  Evaluation of toxicity of a chronic alternate day metronomic cyclophosphamide chemotherapy protocol in dogs with naturally occurring cancer.

Authors:  Arata Matsuyama; J Paul Woods; Anthony J Mutsaers
Journal:  Can Vet J       Date:  2017-01       Impact factor: 1.008

2.  The impact of carboplatin and toceranib phosphate on serum vascular endothelial growth factor (VEGF) and metalloproteinase-9 (MMP-9) levels and survival in canine osteosarcoma.

Authors:  Tracy L Gieger; Julie Nettifee-Osborne; Briana Hallman; Chad Johannes; Dawn Clarke; Michael W Nolan; Laurel E Williams
Journal:  Can J Vet Res       Date:  2017-07       Impact factor: 1.310

3.  High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.

Authors:  Enrico P Spugnini; Sabrina Buglioni; Francesca Carocci; Menicagli Francesco; Bruno Vincenzi; Maurizio Fanciulli; Stefano Fais
Journal:  J Transl Med       Date:  2014-08-21       Impact factor: 5.531

4.  Metronomic Chemotherapy for Palliative Treatment of Malignant Oral Tumors in Dogs.

Authors:  Nina Milevoj; Ana Nemec; Nataša Tozon
Journal:  Front Vet Sci       Date:  2022-03-31

5.  Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.

Authors:  Gauthier Bouche; Nicolas André; Shripad Banavali; Frank Berthold; Alfredo Berruti; Guido Bocci; Giovanni Brandi; Ugo Cavallaro; Saviero Cinieri; Marco Colleoni; Giuseppe Curigliano; Teresa Di Desidero; Alexandru Eniu; Nicola Fazio; Robert Kerbel; Lisa Hutchinson; Urszula Ledzewicz; Elisabetta Munzone; Eddy Pasquier; O Graciela Scharovsky; Yuval Shaked; Jaroslav Stěrba; Martin Villalba; Francesco Bertolini
Journal:  Ecancermedicalscience       Date:  2014-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.